For more information on the harmonization of multiple flow cytometers, join our webinar series on Smart Gain technology here: www.miltenyibiotec.com/lp/flo... What the antibody-related reproducibility crisis means for quality controls in cell manufacturing, and how advances in recombinant antibody technology can help.
This final webinar in our series on reproducibility and consistency in flow cytometry for cell production processes, discusses:
• Antibody-related reproducibility crisis and implications for antibody-based quality controls in cell
manufacturing
• Advances in recombinant antibody technology and opportunities for flow cytometry assays
• Introduction of REAfinity™ Recombinant Antibodies and exemplary data in cell manufacturing
assays
Miltenyi Biotec is a global provider of products and services that advance biomedical research and cellular therapy. Our innovative tools support research at every level, from basic research to translational research to clinical application. This integrated portfolio enables scientists and clinicians to obtain, analyze, and utilize the cell. Our technologies cover the techniques of sample preparation, cell isolation, cell sorting, flow cytometry, cell culture, molecular analysis, and preclinical imaging. Our more than 25 years’ expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer, and clinical research areas like hematology, graft engineering, and apheresis. In our commitment to the scientific community, we also offer comprehensive scientific support, consultation, and expert training. Today, Miltenyi Biotec has more than 2,500 employees in 28 countries - all dedicated to helping researchers and clinicians around the world make a greater impact on science and health.